Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05651204 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GABA Biomarkers in Dravet Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 14, 2022 (before its estimated September 8, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study will non-invasively obtain levels of GABA in the brain of children with SCN1A+DS and neurodeveloping children through evoked and induced cortical responses, correlate them with the BOLD responses, and with the levels of GABA in their blood.
Trial Details
NCT Number NCT05651204
Lead Sponsor Cook Children's Health Care System
Collaborators: Encoded Therapeutics
Conditions
(from sponsor)		 Dravet Syndrome
Related terms Epilepsies, Myoclonic
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov